chr6-64591465-C-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001142800.2(EYS):āc.4402G>Cā(p.Asp1468His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000812 in 1,551,182 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001142800.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EYS | NM_001142800.2 | c.4402G>C | p.Asp1468His | missense_variant | 26/43 | ENST00000503581.6 | NP_001136272.1 | |
EYS | NM_001292009.2 | c.4402G>C | p.Asp1468His | missense_variant | 26/44 | NP_001278938.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EYS | ENST00000503581.6 | c.4402G>C | p.Asp1468His | missense_variant | 26/43 | 5 | NM_001142800.2 | ENSP00000424243.1 | ||
EYS | ENST00000370621.7 | c.4402G>C | p.Asp1468His | missense_variant | 26/44 | 1 | ENSP00000359655.3 |
Frequencies
GnomAD3 genomes AF: 0.000441 AC: 67AN: 152014Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000977 AC: 15AN: 153600Hom.: 0 AF XY: 0.0000736 AC XY: 6AN XY: 81470
GnomAD4 exome AF: 0.0000422 AC: 59AN: 1399168Hom.: 0 Cov.: 35 AF XY: 0.0000304 AC XY: 21AN XY: 690104
GnomAD4 genome AF: 0.000441 AC: 67AN: 152014Hom.: 0 Cov.: 32 AF XY: 0.000377 AC XY: 28AN XY: 74258
ClinVar
Submissions by phenotype
not provided Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Oct 08, 2019 | Reported in the homozygous state in patients with retinitis pigmentosa in published literature, however, these individuals were also homozygous for the c.3443+1G>T pathogenic variant in the EYS gene (Ge et al., 2015; Sengillo et al, 2018); Observed with additional EYS variants, including the c.3443+1G>T pathogenic variant, in an individual with peripheral dystrophy, however, segregation data was not provided to determine whether the variants occurred on the same (in cis) or on different (in trans) chromosomes (Wang et al., 2014); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 25097241, 29550188, 26667666) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Jan 20, 2015 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jun 19, 2018 | The EYS c.4402G>C; p.Asp1468His variant (rs778752557) is reported in the medical literature in two individuals with retinitis pigmentosa, one of whom carried an alternative molecular explanation for disease (Ge 2015, Wang 2014). The variant is described in the ClinVar database (Variation ID: 195938) and is listed in the Genome Aggregation Database with an allele frequency of 0.2% (30/16324 alleles) in the African population. The aspartic acid at codon 1468 is moderately conserved and computational analyses (SIFT: Tolerated, PolyPhen-2: Possibly damaging) predict conflicting effects of this variant on protein structure/function. Although there is information indicating this variant may be likely benign, there is insufficient evidence to classify the variant with certainty. Pathogenic EYS variants are causative for autosomal recessive retinitis pigmentosa (MIM: 602772). References: Ge Z et al. NGS-based Molecular diagnosis of 105 eyeGENE probands with Retinitis Pigmentosa. Sci Rep. 2015 Dec 15;5:18287. Wang J et al. Dependable and efficient clinical utility of target capture-based deep sequencing in molecular diagnosis of retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2014 Aug 5;55(10):6213-23. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 29, 2022 | This sequence change replaces aspartic acid, which is acidic and polar, with histidine, which is basic and polar, at codon 1468 of the EYS protein (p.Asp1468His). This variant is present in population databases (rs778752557, gnomAD 0.2%). This missense change has been observed in individual(s) with retinal disease. However, this variant has frequently been identified on the same chromosome as other EYS variants, making its clinical significance uncertain (PMID: 25097241, 26667666, 29550188). ClinVar contains an entry for this variant (Variation ID: 195938). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on EYS protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Retinitis pigmentosa 25 Uncertain:2
Uncertain significance, criteria provided, single submitter | clinical testing | Counsyl | Mar 06, 2018 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Autosomal recessive retinitis pigmentosa Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Natera, Inc. | Aug 31, 2020 | - - |
EYS-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 28, 2024 | The EYS c.4402G>C variant is predicted to result in the amino acid substitution p.Asp1468His. This variant has been reported in individuals with retinitis pigmentosa; however, in several of these cases it was determined to be on the same allele (in cis) with the pathogenic variant c.3443+1G>T as well as the uncertain missense variant c.3250A>C (p.Thr1084Pro) (Wang et al. 2014. PubMed ID: 25097241; Ge et al. 2015. PubMed ID: 26667666; Sengillo et al. 2018. PubMed ID: 29550188). This variant is reported in 0.20% of alleles in individuals of African descent in gnomAD. Although we suspect that this variant may be benign by itself, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Retinal dystrophy Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Blueprint Genetics | Aug 08, 2019 | - - |
Retinitis pigmentosa Uncertain:1
Uncertain significance, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Apr 01, 2021 | The p.Asp1468His variant in EYS was identified in an individual with Retinitis pigmentosa, via a collaborative study between the Broad Institute's Center for Mendelian Genomics and the Pierce lab (https://oculargenomics.meei.harvard.edu/labs/pierce-lab/lab-members/). Through a review of available evidence we were able to apply the following criteria: PM2, PM3-P. Based on this evidence we have classified this variant as a Variant of Uncertain Significance. If you have any questions about the classification please reach out to the Pierce Lab. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at